Found 7 results
Name | Type of Offering | Accepted Date |
---|---|---|
Genoa Pharmaceuticals, Inc.
|
D/A | 2015-08-11 |
Amount To Be Raised
$2,179,480
Associated Brokers / Dealers
N/A
CIK Number
0001540171
Filed Document
0001140361-15-031315
Exclusions or Exemptions
506b
Accepted Date
2015-08-11
Type of Offering
D/A
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Genoa Pharmaceuticals, Inc.
|
D | 2012-11-16 |
Amount To Be Raised
$1,200,000
Associated Brokers / Dealers
N/A
CIK Number
0001540171
Filed Document
0001540171-12-000003
Exclusions or Exemptions
N/A
Accepted Date
2012-11-16
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Genoa Pharmaceuticals, Inc.
|
D/A | 2015-03-23 |
Amount To Be Raised
$2,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001540171
Filed Document
0001140361-15-013063
Exclusions or Exemptions
506b
Accepted Date
2015-03-23
Type of Offering
D/A
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Genoa Pharmaceuticals, Inc.
|
D | 2017-03-24 09:32:26 |
Amount To Be Raised
$62,878,616
Associated Brokers / Dealers
N/A
CIK Number
0001540171
Filed Document
0001140361-17-013115
Exclusions or Exemptions
506b
Accepted Date
2017-03-24 09:32:26
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Genoa Pharmaceuticals, Inc.
|
D/A | 2017-05-24 16:39:12 |
Amount To Be Raised
$64,915,611
Associated Brokers / Dealers
N/A
CIK Number
0001540171
Filed Document
0001140361-17-022149
Exclusions or Exemptions
506b
Accepted Date
2017-05-24 16:39:12
Type of Offering
D/A
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
WASHINGTON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Avalyn Pharma Inc.
|
D | 2020-05-07 18:02:48 |
Amount To Be Raised
$35,695,957
Associated Brokers / Dealers
N/A
CIK Number
0001540171
Filed Document
0001540171-20-000002
Exclusions or Exemptions
506b
Accepted Date
2020-05-07 18:02:48
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
WASHINGTON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Avalyn Pharma Inc.
|
D | 2023-10-10 12:48:11 |
Amount To Be Raised
$189,182,622
Associated Brokers / Dealers
N/A
CIK Number
0001540171
Filed Document
0001540171-23-000001
Exclusions or Exemptions
506b
Accepted Date
2023-10-10 12:48:11
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
WASHINGTON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|